腓骨肌萎缩症4型遗传学研究进展

doi:10.16288/j.yczz.14-412

遗传 ›› 2015, Vol. 37 ›› Issue (6): 501-509.doi: 10.16288/j.yczz.14-412

• 综述 • 下一篇

腓骨肌萎缩症4型遗传学研究进展

许烨¹, 张嘉莹¹, 杨博宇¹, 何志宏¹, 张慕晨¹, 于珍², 顾鸣敏²

1. 上海交通大学医学院,上海 200025;
2. 上海交通大学医学院医学遗传学教研室,上海 200025

收稿日期:2014-11-25 修回日期:2015-03-25 出版日期:2015-06-20 发布日期:2015-06-20
通讯作者: 顾鸣敏,教授,硕士生导师,研究方向：遗传病的基因定位和功能研究。E-mail: gumm@sjtu.edu.cn
作者简介:许烨,临床医学专业八年制学生,专业方向：临床医学。E-mail: 136965680@qq.com
基金资助:
国家自然科学基金项目(编号：30470951, 31071107)资助

Advances in genetic studies of Charcot-Marie-Tooth disease type 4 (CMT4)

Ye Xu¹, Jiaying Zhang¹, Boyu Yang¹, Zhihong He¹, Muchen Zhang¹, Zhen Yu², Mingmin Gu²

1. School of Medicine, Shanghai Jiao Tong University Shanghai 200025, China;
2. Department of Medical Genetics, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Received:2014-11-25 Revised:2015-03-25 Online:2015-06-20 Published:2015-06-20

摘要/Abstract

摘要： 腓骨肌萎缩症也称夏科-马利-杜斯氏病(Charcot-Marie-Tooth disease, CMT),是人类最常见的遗传性周围神经病之一,其遗传方式以常染色体显性遗传为主,也有部分呈常染色体隐性遗传或X连锁显性或隐性遗传。根据临床表型将CMT分为脱髓鞘型(CMT1)、轴突型(CMT2)和中间型（DI-CMT）。常染色体隐性遗传的CMT1(AR-CMT1,也称CMT4型)临床表现除了CMT常见的四肢远端进行性肌无力和萎缩,以及高足弓和爪形手外,常起病早,进展迅速,并有不同程度的感觉障碍和脊柱畸形(以脊柱侧凸为主)。近年来的研究显示,CMT4有11种亚型,其中有些亚型的致病机制较明确,有些亚型存在建立者突变,有些亚型还局限在临床描述和突变检出上。文章综述了CMT4的最新研究进展,包括各亚型的临床表现、致病机制和小鼠模型等。

关键词: 腓骨肌萎缩症, CMT4型, 致病机制, 小鼠模型

Abstract: The Charcot-Marie-Tooth disease (CMT) is one of the most common human inherited peripheral neuropathies. The most common pattern of inheritance is autosomal dominant, with less often occurrence autosomal recessive and X-linked dominant/recessive inheritance. CMT is generally divided into three forms: demyelinating forms (CMT1), axonal forms (CMT2) and intermediate forms (DI-CMT). The autosomal recessive form (AR-CMT1 or CMT4) is accompanied by progressive distal muscle weakness and atrophy of the limbs, pes cavus and claw-like hands. In addition, CMT4 is also characterized by early onset, rapid progression, and varying degrees of sensory loss and spinal deformities (e.g. scoliosis). Recently, 11 subtypes of CMT4 have been identified. Some of these subtypes were clear in pathogenic mechanisms, some had founder mutation, but some still had limited clinical description and mutation analysis. In this review, we summarize the latest research progresses of CMT4, including genotypes and phenotypes, pathogenic mechanisms and mouse models.

Key words: Charcot-Marie-Tooth disease, CMT type 4, pathogenic mechanism, mouse model

许烨, 张嘉莹, 杨博宇, 何志宏, 张慕晨, 于珍, 顾鸣敏. 腓骨肌萎缩症4型遗传学研究进展[J]. 遗传, 2015, 37(6): 501-509.

Ye Xu, Jiaying Zhang, Boyu Yang, Zhihong He, Muchen Zhang, Zhen Yu, Mingmin Gu. Advances in genetic studies of Charcot-Marie-Tooth disease type 4 (CMT4)[J]. HEREDITAS(Beijing), 2015, 37(6): 501-509.

参考文献

[1] Lupski JR, Reid JG, Gonzaga-Jauregui C, Rio Deiros D, Chen DC, Nazareth L, Bainbridge M, Dinh H, Jing C, Wheeler DA, McGuire AL, Zhang F, Stankiewicz P, Halperin JJ, Yang C, Gehman C, Guo D, Irikat RK, Tom W, Fantin NJ, Muzny DM, Gibbs RA. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med , 2010, 362(13): 1181-1191.
[2] Rossor AM, Polke JM, Houlden H, Reilly MM. Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat Rev Neurol , 2013, 9(10): 562-571.
[3] Xu WY, Gu MM, Sun LH, Guo WT, Zhu HB, Ma JF, Yuan WT, Kuang Y, Ji BJ, Wu XL, Chen Y, Zhang HX, Sun FT, Huang W, Huang L, Chen SD, Wang ZG. A nonsense mutation in DHTKD1 causes Charcot-Marie-Tooth disease type 2 in a large Chinese pedigree. Am J Hum Genet , 2012, 91(6): 1088-1094.
[4] Claeys KG, Lammens M, Senderek J, Weis J. Autosomal recessive demyelinating or axonal Charcot-Marie-Tooth neuropathy. In: Vallat JM, Director JW. Peripheral nerve disorders: pathology and genetics. UK: The International Society of Neuropathology, 2014: 85-101.
[5] Baxter RV, Ben Othmane K, Rochelle JM, Stajich JE, Hulette C, Dew-Knight S, Hentati F, Ben Hamida M, Bel S, Stenger JE, Gilbert JR, Pericak-Vance MA, Vance JM. Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat Genet , 2002, 30(1): 21-22.
[6] Niemann A, Ruegg M, La Padula V, Schenone A, Suter U. Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease. J Cell Biol , 2005, 170(7): 1067-1078.
[7] Pedrola L, Espert A, Wu XY, Claramunt R, Shy ME, Palau F. GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria. Hum Mol Genet , 2005, 14(8): 1087-1094.
[8] Niemann A, Huber N, Wagner KM, Somandin C, Horn M, Lebrun-Julien F, Angst B, Pereira JA, Halfter H, Welzl H, Feltri ML, Young P, Wessig C, Toyka KV, Suter U. The Gdap1 knockout mouse mechanistically links redox control to Charcot-Marie-Tooth disease. Brain , 2014, 137(Pt 3): 668-682.
[9] Noack R, Frede S, Albrecht P, Henke N, Pfeiffer A, Knoll K, Dehmel T, Meyer Zu Hörste G, Stettner M, Kieseier BC, Summer H, Golz S, Kochanski A, Wiedau-Pazos M, Arnold S, Lewerenz J, Methner A. Charcot-Marie-Tooth disease CMT4A: GDAP1 increases cellular glutathione and the mitochondrial membrane potential. Hum Mol Genet , 2012, 21(1): 150-162.
[10] Tazir M, Bellatache M, Nouioua S, Vallat JM. Autosomal recessive Charcot-Marie-Tooth disease: from genes to phenotypes. J Peripher Nerv Syst , 2013, 18(2): 113-129.
[11] Bolino A, Bolis A, Previtali SC, Dina G, Bussini S, Dati G, Amadio S, Del Carro U, Mruk DD, Feltri ML, Cheng CY, Quattrini A, Wrabetz L. Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis. J Cell Biol , 2004, 167(4): 711-721.
[12] Berger P, Berger I, Schaffitzel C, Tersar K, Volkmer B, Suter U. Multi-level regulation of myotubularin-related protein-2 phosphatase activity by myotubularin-related protein-13/set-binding factor-2. Hum Mol Genet , 2006, 15(4): 569-579.
[13] Robinson FL, Dixon JE. The phosphoinositide-3-phosphatase MTMR2 associates with MTMR13, a membrane-associated pseudophosphatase also mutated in type 4B Charcot-Marie-Tooth disease. J Biol Chem , 2005, 280(36): 31699-316707.
[14] Tersar K, Boentert M, Berger P, Bonneick S, Wessig C, Toyka KV, Young P, Suter U. Mtmr13/Sbf2-deficient mice: an animal model for CMT4B2. Hum Mol Genet , 2007, 16(24): 2991-3001.
[15] Robinson FL, Niesman IR, Beiswenger KK, Dixon JE. Loss of the inactive myotubularin-related phosphatase Mtmr13 leads to a Charcot-Marie-Tooth 4B2-like peripheral neuropathy in mice. Proc Natl Acad Sci USA , 2008, 105(12): 4916-4921.
[16] Ng AA, Logan AM, Schmidt EJ, Robinson FL. The CMT4B disease-causing phosphatases Mtmr2 and Mtmr13 localize to the Schwann cell cytoplasm and endomembrane compartments, where they depend upon each other to achieve wild-type levels of protein expression. Hum Mol Genet , 2013, 22(8): 1493-1506.
[17] Nakhro K, Park JM, Hong YB, Park JH, Nam SH, Yoon BR, Yoo JH, Koo H, Jung SC, Kim HL, Kim JY, Choi KG, Choi BO, Chung KW. SET binding factor 1 ( SBF1 ) mutation causes Charcot-Marie-Tooth disease type 4B3. Neurology , 2013, 81(2): 165-173.
[18] Arnaud E, Zenker J, de Preux Charles AS, Stendel C, Roos A, Médard JJ, Tricaud N, Kleine H, Luscher B, Weis J, Suter U, Senderek J, Chrast R. SH3TC2/KIAA1985 protein is required for proper myelination and the integrity of the node of Ranvier in the peripheral nervous system. Proc Natl Acad Sci USA , 2009, 106(41): 17528-17533.
[19] Colomer J, Gooding R, Angelicheva D, King RHM, Guillén-Navarro E, Parman Y, Nascimento A, Conill J, Kalaydjieva L. Clinical spectrum of CMT4C disease in patients homozygous for the p.Arg1109X mutation in SH3TC2 . Neuromuscul Disord , 2006, 16(7): 449-453.
[20] LeGuern E, Guilbot A, Kessali M, Ravisé N, Tassin J, Maisonobe T, Grid D, Brice A. Homozygosity mapping of an autosomal recessive form of demyelinating Charcot-Marie-Tooth disease to chromosome 5q23-q33. Hum Mol Genet , 1996, 5(10): 1685-1688.
[21] Yger M, Stojkovic T, Tardieu S, Maisonobe T, Brice A, Echaniz-Laguna A, Alembik Y, Girard S, Cazeneuve C, LeGuern E, Dubourg O. Characteristics of clinical and electrophysiological pattern of Charcot-Marie-Tooth 4C. J Peripher Nerv Syst , 2012, 17(1): 112-122.
[22] Iguchi M, Hashiguchi A, Ito E, Toda K, Urano M, Shimizu Y, Takeuchi C, Saito K, Takashima H, Uchiyama S. Charcot-marie-tooth disease type 4C in Japan: Report of a case. Muscle Nerve , 2013, 47(2): 283-286.
[23] Houlden H, Laura M, Ginsberg L, Jungbluth H, Robb SA, Blake J, Robinson S, King RHM, Reilly MM. The phenotype of Charcot-Marie-Tooth disease type 4C due to SH3TC2 mutations and possible predisposition to an inflammatory neuropathy. Neuromuscul Disord , 2009, 19(4): 264-269.
[24] Kalaydjieva L, Gresham D, Gooding R, Heather L, Baas F, de Jonge R, Blechschmidt K, Angelicheva D, Chandler D, Worsley P, Rosenthal A, King RHM, Thomas PK. N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Am J Hum Genet , 2000, 67(1): 47-58.
[25] Roberts RC, Peden AA, Buss F, Bright NA, Latouche M, Reilly MM, Kendrick-Jones J, Luzio JP. Mistargeting of SH3TC2 away from the recycling endosome causes Charcot-Marie-Tooth disease type 4C. Hum Mol Genet , 2010, 19(6): 1009-1018.
[26] Lupo V, Galindo MI, Martínez-Rubio D, Sevilla T, Vílchez JJ, Palau F, Espinós C. Missense mutations in the SH3TC2 protein causing Charcot-Marie-Tooth disease type 4C affect its localization in the plasma membrane and endocytic pathway. Hum Mol Genet , 2009, 18(23): 4603-4614.
[27] Stendel C, Roos A, Kleine H, Arnaud E, Özçelik M, Sidiropoulos PNM, Zenker J, Schüpfer F, Lehmann U, Sobota RM, Litchfield DW, Lüscher B, Chrast R, Suter U, Senderek J. SH3TC2, a protein mutant in Charcot-Marie- Tooth neuropathy, links peripheral nerve myelination to endosomal recycling. Brain , 2010, 133(8): 2462-2474.
[28] Kalaydjieva L, Nikolova A, Turnev I, Petrova J, Hristova A, Ishpekova B, Petkova I, Shmarov A, Stancheva S, Middleton L, Merlini L, Trogu A, Muddle JR, King RH, Thomas PK. Hereditary motor and sensory neuropathy——Lom, a novel demyelinating neuropathy associated with deafness in gypsies. Clinical, electrophysiological and nerve biopsy findings. Brain , 1998, 121(3): 399-408.
[29] Kalaydjieva L, Hallmayer J, Chandler D, Savov A, Nikolova A, Angelicheva D, King RHH, Ishpekova B, Honeyman K, Calafell F, Shmarov A, Petrova J, Turnev I, Hristova A, Moskov M, Stancheva S, Petkova I, Bittles AH, Georgieva V, Middleton L, Thomas PK. Gene mapping in Gypsies identifies a novel demyelinating neuropathy on chromosome 8q24. Nat Genet , 1996, 14(2): 214-217.
[30] Pietiäinen V, Vassilev B, Blom T, Wang W, Nelson J, Bittman R, Bäck1 N, Zelcer N, Ikonen E. NDRG1 functions in LDL receptor trafficking by regulating endosomal recycling and degradation. J Cell Sci , 2013, 126(17): 3961-3971.
[31] Warner LE, Mancias P, Butler IJ, McDonald CM, Keppen L, Koob KG, Lupski JR. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet , 1998, 18(4): 382-384.
[32] Warner LE, Svaren J, Milbrandt J, Lupski JR. Functional consequences of mutations in the early growth response 2 gene ( EGR2 ) correlate with severity of human myelinopathies. Hum Mol Genet , 1999, 8(7): 1245-1251.
[33] Topliko P, Schneider-Maunoury S, Levi G, Baron-Van Evercooren A, Chennoufi ABY, Seitanidou T, Babinet C, Charnay P. Krox-20 controls myelination in the peripheral nervous system. Nature , 1994, 371(6500): 796-799.
[34] Decker L, Desmarquet-Trin-Dinh C, Taillebourg E, Ghislain J, Vallat JM, Charnay P. Peripheral myelin maintenance is a dynamic process requiring constant Krox20 expression. J Neurosci , 2006, 26(38): 9771-9779.
[35] Espinós C, Calpena E, Martínez-Rubio D, Lupo V. Autosomal recessive Charcot-Marie-Tooth neuropathy. Adv Exp Med Biol , 2012, 724: 61-75.
[36] Guilbot A, Williams A, Ravisé N, Verny C, Brice A, Sherman DL, Brophy PJ, LeGuern E, Delague V, Bareil C, Mégarbané A, Claustres M. A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum Mol Genet , 2001, 10(4): 415-421.
[37] Williams AC, Brophy PJ. The function of the Periaxin gene during nerve repair in a model of CMT4F. J Anat , 2002, 200(4): 323-330.
[38] Sevilla T, Martínez-Rubio D, Márquez C, Paradas C, Colomer J, Jaijo T, Millán JM, Palau F, Espinós C. Genetics of the Charcot-Marie-Tooth disease in the Spanish Gypsy population: the hereditary motor and sensory neuropathy-Russe in depth. Clin Genet , 2013, 83(6): 565-570.
[39] Hantke J, Chandler D, King R, Wanders RJA, Angelicheva D, Tournev I, McNamara E, Kwa M, Guergueltcheva V, Kaneva R, Baas F, Kalaydjieva L. A mutation in an alternative untranslated exon of hexokinase 1 associated with hereditary motor and sensory neuropathy-Russe (HMSNR). Eur J Hum Genet , 2009, 17(12): 1606-1614.
[40] Delague V, Jacquier A, Hamadouche T, Poitelon Y, Baudot C, Boccaccio I, Chouery E, Chaouch M, Kassouri N, Jabbour R, Grid D, Mégarbané A, Haase G, Lévy N. Mutations in FGD4 encoding the Rho GDP/GTP exchange factor frabin cause autosomal recessive Charcot-Marie- Tooth type 4H. Am J Hum Genet , 2007, 81(1): 1-16.
[41] Horn M, Baumann R, Pereira JA, Sidiropoulos PNM, Somandin C, Welzl H, Stendel C, Lühmann T, Wessig C, Toyka KV, Relvas JB, Senderek J, Suter U. Myelin is dependent on the Charcot-Marie-Tooth Type 4H disease culprit protein FRABIN/FGD4 in Schwann cells. Brain , 2012, 135(12): 3567-3583.
[42] Chow CY, Zhang YL, Dowling JJ, Jin N, Adamska M, Shiga K, Szigeti K, Shy ME, Li J, Zhang XB, Lupski JR, Weisman LS, Meisler MH. Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature , 2007, 448(7149): 68-72.
[43] Nicholson G, Lenk GM, Reddel SW, Grant AE, Towne CF, Ferguson CJ, Simpson E, Scheuerle A, Yasick M, Hoffman S, Blouin R, Brandt C, Coppola G, Biesecker LG, Batish SD, Meisler MH. Distinctive genetic and clinical features of CMT4J: a severe neuropathy caused by mutations in the PI(3,5)P 2 phosphatase FIG4. Brain , 2011, 134(7): 1959-1971.
[44] Chow CY, Landers JE, Bergren SK, Sapp PC, Grant AE, Jones JM, Everett L, Lenk GM, McKenna-Yasek DM, Weisman LS, Figlewicz D, Brown RH, Meisler MH. Deleterious variants of FIG4 , a phosphoinositide phosphatase, in patients with ALS. Am J Hum Genet , 2009, 84(1): 85-88.
[45] Lenk GM, Ferguson CJ, Chow CY, Jin N, Jones JM, Grant AE, Zolov SN, Winters JJ, Giger RJ, Dowling JJ, Weisman LS, Meisler MH. Pathogenic mechanism of the FIG4 mutation responsible for Charcot-Marie-Tooth disease CMT4J. PLoS Genet , 2011, 7(6): e1002104.
[46] Dubourg O, Azzedine H, Verny C, Durosier G, Birouk N, Gouider R, Salih M, Bouhouche A, Thiam A, Grid D, Mayer M, Ruberg M, Tazir M, Brice A, LeGuern E. Autosomal-recessive forms of demyelinating Charcot-Marie- Tooth disease. Neuromolecular Med , 2006, 8(1-2): 75-86.
(责任编委: 夏昆)

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

腓骨肌萎缩症4型遗传学研究进展

Advances in genetic studies of Charcot-Marie-Tooth disease type 4 (CMT4)

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 8

编辑推荐

Metrics

[1]	孟晓伟, 汪洁, 马晴雯. 唐氏综合征小鼠模型的遗传背景和应用[J]. 遗传, 2018, 40(3): 207-217.
[2]	刘林玉, 杜司晨, 张进, 马端. 戈谢氏病致病机制及治疗方法[J]. 遗传, 2015, 37(6): 510-516.
[3]	吴日,马超,李晓丹,段会坤,姬艳丽,王宇,姜苹哲,王海松,屠培培,李淼,尼钢钢,马百成,李明刚. 长效促胰岛素降糖酵母的构建及其对糖尿病模型小鼠的治疗效果[J]. 遗传, 2015, 37(2): 183-191.
[4]	汪启翰,怀聪,孙瑞林,庄华,陈红岩,费俭,卢大儒. 利用CRISPR/Cas系统快速高效构建血友病乙小鼠模型[J]. 遗传, 2015, 37(11): 1143-1148.
[5]	于珍, 栾春杰, 顾鸣敏. 腓骨肌萎缩症2型(CMT2)小鼠模型的研究进展[J]. 遗传, 2014, 36(1): 21-29.
[6]	张如旭，郭鹏，任志军，赵国华，刘三妹，刘婷，资晓宏，胡正茂，夏昆，唐北沙. LITAF、RAB7、LMNA和MTMR2基因在中国人腓骨肌萎缩症患者的突变分析[J]. 遗传, 2010, 32(8): 817-823.
[7]	贾舒婷，杨世华，罗瑛. Werner综合征小鼠模型在早衰与肿瘤研究中的应用[J]. 遗传, 2009, 31(8): 785-790.
[8]	宋书娟，闫明，王小竹，章远志，邹俊华，钟南. 在两个X连锁显性腓骨肌萎缩症家系中发现同一GJB1基因突变Glu208Lys[J]. 遗传, 2007, 29(7): 800-804.